Partial prevention of glucocorticoid-induced osteocyte deterioration in young male mice with osteocrin gene therapy
Summary: Glucocorticoid excess suppresses osteocyte remodeling of surrounding bone minerals, causes apoptosis of osteoblasts and osteocytes, and disrupts bone remodeling, eventually, leading to glucocorticoid-induced osteoporosis and bone fragility. Preventing apoptosis and preserving osteocyte morp...
Main Authors: | Courtney M. Mazur, Christian D. Castro Andrade, Nicha Tokavanich, Tadatoshi Sato, Michael Bruce, Daniel J. Brooks, Mary L. Bouxsein, Jialiang S. Wang, Marc N. Wein |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004222012913 |
Similar Items
-
Control of osteocyte dendrite formation by Sp7 and its target gene osteocrin
by: Jialiang S. Wang, et al.
Published: (2021-11-01) -
Comparative study in estrogen-depleted mice identifies skeletal and osteocyte transcriptomic responses to abaloparatide and teriparatide
by: Zhengtao Lv, et al.
Published: (2023-10-01) -
Biosynthesis of glucocorticoids in tumors
by: Nicola Cirillo
Published: (2023-11-01) -
Osteoclast-derived IGF1 induces RANKL production in osteocytes and contributes to pagetic lesion formation
by: Kazuaki Miyagawa, et al.
Published: (2023-07-01) -
Glucocorticoid-induced Stress Mechanism in Mouse Primary Neurons
by: Stephen Prevoznik
Published: (2023-05-01)